Author pages are created from data sourced from our academic publisher partnerships and public sources.
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
- M. Cavo, P. Tosi, +17 authors M. Baccarani
- Journal of clinical oncology : official journal…
- 10 June 2007
PURPOSE We performed a prospective, randomized study of single (arm A) versus double (arm B) autologous stem-cell transplantation (ASCT) for younger patients with newly diagnosed multiple myeloma… Expand
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed…
In a randomized, phase 3 study, superior complete/near-complete response (CR/nCR) rates and extended progression-free survival were demonstrated with bortezomib-thalidomide-dexamethasone (VTD) versus… Expand
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Thalidomide has emerged as an active agent for the management of advanced multiple myeloma (MM) and is currently under investigation also in patients with newly diagnosed disease. It is… Expand
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
BACKGROUND AND OBJECTIVES Few therapeutic options are presently available for patients with multiple myeloma (MM) who relapse after autologous or allogeneic stem cell transplantation, or for patients… Expand
Dysphagia after definitive radiotherapy for head and neck cancer
- L. Deantonio, L. Masini, M. Brambilla, F. Pia, M. Krengli
- Strahlentherapie und Onkologie
- 16 January 2013
BackgroundDysphagia is a complication of head and neck cancer patients undergoing radiotherapy (RT). We analysed frequency and severity of swallowing dysfunction and correlated these findings with… Expand
Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients
- S. Pozzi, R. Marcheselli, +23 authors On behalf of the Gruppo Italiano Studio Linfomi
- Leukemia & lymphoma
- 1 January 2007
Over a period of 28 months, we observed five cases of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates (BP) at our institution. This prompted us to undertake a… Expand
Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres
Summary. A retrospective survey was conducted over a 10‐year period (1990–99) among 52 haematology divisions in order to evaluate the clinical and laboratory characteristics and outcome of patients… Expand
A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD…
Abstract 351 Introduction A phase III study of melphalan (200 mg/m2)-based double autologous stem-cell transplantation (ASCT) incorporating thalidomide (T) and dexamethasone (D) with or without the… Expand
Sacrococcygeal teratoma. Outcome and management. An analysis of 17 cases
Abstract Aims: The authors compare their experience of 17 cases of sacrococcygeal teratoma (SCT) with the literature in an attempt to clarify the natural history of this tumor and to identify factors… Expand
A biochemical protocol for the isolation and identification of current species of Vibrio in seafood
- D. Ottaviani, L. Masini, S. Bacchiocchi
- Medicine, Biology
- Journal of applied microbiology
- 1 December 2003
Aims: We report a biochemical method for the isolation and identification of the current species of vibrios using just one operative protocol.